RIGEL PHARMACEUTICALS INC short interest in 2022
In 2022, RIGEL PHARMACEUTICALS INC's disclosed short interest ran from 9.05% of shares outstanding on 14 Jan 2022 to 3.11% on 30 Dec 2022, a change of -5.94 percentage points. The year's high was 9.19% on 31 Jan 2022 and its low 2.34% on 30 Nov 2022, averaging 5.39% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.56 days on 14 Jan 2022. Full history: RIGEL PHARMACEUTICALS INC.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 9.05% (14 Jan 2022)
- End of year
- 3.11% (30 Dec 2022)
- Change
- -5.94 pp
- High
- 9.19% (31 Jan 2022)
- Low
- 2.34% (30 Nov 2022)
- Average
- 5.39%
- Highest days to cover
- 9.56 (14 Jan 2022)
- SEC filings marked
- 9
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 9.05% | 9.56 | results (8-K) |
| 31 Jan 2022 | 9.19% | 8.70 | |
| 15 Feb 2022 | 8.16% | 9.55 | |
| 28 Feb 2022 | 8.43% | 8.99 | |
| 15 Mar 2022 | 7.51% | 5.02 | 10-K filed, results (8-K) |
| 31 Mar 2022 | 5.84% | 4.12 | |
| 14 Apr 2022 | 5.13% | 6.36 | |
| 29 Apr 2022 | 3.85% | 4.63 | |
| 13 May 2022 | 3.89% | 3.20 | 10-Q filed, results (8-K) |
| 31 May 2022 | 4.06% | 3.68 | |
| 15 Jun 2022 | 4.14% | 1.00 | |
| 30 Jun 2022 | 6.71% | 1.08 | |
| 15 Jul 2022 | 6.07% | 2.83 | |
| 29 Jul 2022 | 5.80% | 3.35 | |
| 15 Aug 2022 | 5.43% | 2.12 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 5.45% | 2.82 | |
| 15 Sep 2022 | 6.33% | 2.77 | |
| 30 Sep 2022 | 4.41% | 1.55 | |
| 14 Oct 2022 | 4.15% | 2.59 | |
| 31 Oct 2022 | 3.45% | 4.25 | |
| 15 Nov 2022 | 3.19% | 3.68 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 2.34% | 2.66 | |
| 15 Dec 2022 | 3.69% | 1.00 | |
| 30 Dec 2022 | 3.11% | 1.36 |
See also: RIGEL PHARMACEUTICALS INC's full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.